NorthStar Secures Up to $185 Million Growth Financing Led by Hercules Capital to Scale Actinium-225 Production and Radiopharmaceutical Manufacturing for Next-Generation Precision Cancer Therapies

Go back to NorthStar Secures Up to $185 Million Growth Financing Led by Hercules Capital to Scale Actinium-225 Production and Radiopharmaceutical Manufacturing for Next-Generation Precision Cancer Therapies
HERCULES TECHNOLOGY GROWTH CAPITAL, Inc. (NYSE: HTGC) Delayed: 16.27 -0.01 (0.06%)
Previous Close $16.28    52 Week High $14.00 
Open $16.36    52 Week Low $9.92 
Day High $16.36    P/E 9.24 
Day Low $16.20    EPS $1.76 
Volume 909,371